SnagRx vs Luvo Health: Compounded GLP-1 pricing and policies
Quick verdict: For transparent, bottom‑of‑market annual pricing and named pharmacy and clinician partners, SnagRx is the clearer choice; Luvo Health’s public landing page captured here did not verify pricing, eligibility or state coverage details.
See SnagRx semaglutide from $69/mo
SnagRx vs Luvo Health: how they differ at a glance
This comparison reviews the primary, supported differences between SnagRx and Luvo Health using only captured facts. The most distinctive differences are pricing transparency and plan terms, use of compounded medications and regulatory notes, named clinician and pharmacy partnerships and shipping/fulfillment details, and the clarity of eligibility, state coverage and renewal terms.
1. Pricing transparency and plan commitments
SnagRx: Compounded semaglutide is advertised from $69/month on the 12-month plan and compounded tirzepatide from $119/month on the 12-month plan. SnagRx states those $69 and $119 figures are the 12-month plan rates; month-to-month equivalents are $99 and $149. The site emphasizes a price locked flat at every dose and at renewal for the life of treatment on the annual plan.
Check SnagRx annual pricing and terms
Luvo Health: The captured landing-page content did not verify a specific starting price or concrete month-to-month versus annual rates. The Luvo page references ongoing support, dose changes and stages such as MONTH 1, MONTH 2–3 and 3+ MONTHS, but current pricing figures and detailed renewal terms were not published or could not be verified in the captured material. Readers should confirm Luvo Health pricing and renewal terms directly with Luvo before enrolling.
2. Compounded medications and regulatory notes
SnagRx: Offers compounded semaglutide and tirzepatide and explicitly states these are compounded medications produced in FDA-regulated facilities but that compounded medications are not FDA-approved finished products. SnagRx also notes that the decision to use compounded drugs is guided by the licensed provider’s medical judgment and that medications may look different than portrayed.
Luvo Health: The captured content likewise notes that compounded medications, when offered, are prepared by licensed pharmacies and are not reviewed or approved by the FDA. The Luvo material emphasizes treatment is available only when a licensed clinician determines it is medically appropriate.
3. Clinician network, eligibility and state coverage
SnagRx: Names OpenLoop Health as its clinician network and states OpenLoop clinicians cover 48 states. SnagRx explains that OpenLoop Health clinicians use exclusionary criteria to screen eligibility, that a clinician meets patients after checkout, and that clinicians retain prescribing decisions. SnagRx also states clinicians typically review intake within five hours and always within 24.
Luvo Health: The captured landing page indicates treatment is available only when a licensed clinician determines it is medically appropriate, but the captured material did not verify which clinician network, which states are covered or current state availability. The page suggests dose adjustments based on clinical response and cancel anytime policies, but detailed state coverage or named clinician partners were not published in the capture.
4. Shipping, fulfillment and refunds
SnagRx: States next-day UPS/FedEx shipping in temperature-controlled packaging, names its US 503A partner pharmacies, and says a declined prescription is refunded in full. SnagRx advertises free shipping and arrival in 1-2 days for approved orders.
Luvo Health: The captured content did not publish specific shipping times, named pharmacies or explicit refund details in the captured affiliate landing page. It does display program stages and mentions cancel anytime, but captured shipping and refund specifics were not verified.
5. Support and programming
SnagRx: The captured evidence notes prescription and telemed visits are included and that SnagRx does not provide coaching or nutrition programming. It also advertises outcome-related claims and a 6-month weight-loss guarantee with terms applying.
Luvo Health: The captured content highlights ongoing support, dose changes and educational content such as guides and articles, but captured pros and cons, and many operational details like pricing and state coverage, were not verified on the landing page material we reviewed.
Comparison table: SnagRx vs Luvo Health
| Criteria | SnagRx | Luvo Health |
|---|---|---|
| Starting price (captured) | Semaglutide from $69/month on 12-month plan; month-to-month $99 | Not verified on captured landing page |
| Price lock / renewal | Price locked flat at every dose and at renewal on annual plan | Not published or not verified in capture |
| Medication type | Compounded semaglutide and tirzepatide | Compounded medications offered when applicable; not FDA-approved |
| Clinician network / state coverage | OpenLoop Health network; clinicians cover 48 states | Clinician review required; named network and state coverage not verified |
| Shipping / fulfillment | Next-day UPS/FedEx; free shipping; named US 503A pharmacies | Shipping details not verified on captured page |
| Coaching / programming | No coaching or nutrition programming captured | Ongoing support and educational content referenced; specifics not verified |
How to choose between SnagRx and Luvo Health
Choose SnagRx if you need explicit captured pricing that starts at $69/month on a 12-month plan, want a stated price lock at every dose and prefer named pharmacy and clinician partners with next-day shipping and clinician review timelines.
Review Luvo Health program details
Choose Luvo Health if you prefer to confirm eligibility, exact medication options, total cost, renewal terms and state availability with Luvo directly, because these details were not verified on the captured landing page.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →